Literature DB >> 10767737

Course of objective memory impairment in non-demented subjects attending a memory clinic and predictors of outcome.

P J Visser1, F R Verhey, R W Ponds, M Cruts, C L Van Broeckhoven, J Jolles.   

Abstract

The aim of the study was to investigate the course of objective memory impairment in non-demented subjects who attended a memory clinic and to test predictors of outcome. Non-demented subjects (N=74) were included when they were older than 40 years and had a baseline score on the delayed recall of a word learning test below the tenth percentile. Subjects with memory impairment due to known somatic or neurological causes were excluded. The subjects were reassessed after 2 and 5 years. At the 5-year follow-up, 42% of the subjects had no memory impairment, 19% of the subjects had memory impairment without dementia, and 39% of the subjects had Alzheimer type dementia (AD). Predictors at baseline of reversible memory impairment in a multivariate analysis were age, scores on the MMSE and delayed recall, and the degree of functional impairment. Predictors at baseline of AD in a multivariate analysis were age and the score on the MMSE. The apolipoprotein E genotype and the presence of depression at baseline were not predictors of outcome. The positive predictive value was 72% for reversible memory impairment and 81% for AD. Memory impairment is often reversible and therefore its presence alone is not sufficient to consider subjects as preclinically demented. Predictive accuracy can be increased by including simple measures such as age, the scores on the MMSE and delayed recall, and the degree of functional impairment. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2000        PMID: 10767737     DOI: 10.1002/(sici)1099-1166(200004)15:4<363::aid-gps129>3.0.co;2-4

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  11 in total

Review 1.  Memory clinics.

Authors:  D Jolley; S M Benbow; M Grizzell
Journal:  Postgrad Med J       Date:  2006-03       Impact factor: 2.401

2.  Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment.

Authors:  P J Visser; F R J Verhey; P A M Hofman; P Scheltens; J Jolles
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

3.  Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease?

Authors:  P J Visser; P Scheltens; F R J Verhey
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-10       Impact factor: 10.154

4.  Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment.

Authors:  Danielle C Whitehair; Abdullah Sherzai; Jennifer Emond; Rema Raman; Paul S Aisen; Ronald C Petersen; Adam S Fleisher
Journal:  Alzheimers Dement       Date:  2010-09       Impact factor: 21.566

Review 5.  Category cued recall following controlled encoding as a neuropsychological tool in the diagnosis of Alzheimer's disease: a review of the evidence.

Authors:  Giovanni Augusto Carlesimo; Roberta Perri; Carlo Caltagirone
Journal:  Neuropsychol Rev       Date:  2010-11-18       Impact factor: 7.444

6.  Mild cognitive impairment in different functional domains and incident Alzheimer's disease.

Authors:  N T Aggarwal; R S Wilson; T L Beck; J L Bienias; D A Bennett
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-11       Impact factor: 10.154

7.  Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful.

Authors:  J Tian; R S Bucks; J Haworth; G Wilcock
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

8.  Apolipoprotein ε4-allele as a significant risk factor for conversion from mild cognitive impairment to Alzheimer's disease: a meta-analysis of prospective studies.

Authors:  Ma Fei; Wang Jianhua
Journal:  J Mol Neurosci       Date:  2012-12-15       Impact factor: 3.444

9.  Persistence of neuropsychological testing deficits in mild cognitive impairment.

Authors:  Edmond Teng; Kathleen D Tingus; Po H Lu; Jeffrey L Cummings
Journal:  Dement Geriatr Cogn Disord       Date:  2009-08-26       Impact factor: 2.959

Review 10.  Prevention of Alzheimer disease. Encouraging evidence.

Authors:  Monica Zavaloni Scalco; Robert van Reekum
Journal:  Can Fam Physician       Date:  2006-02       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.